Literature DB >> 23871665

Thermodynamic stabilization of the folded domain of prion protein inhibits prion infection in vivo.

Qingzhong Kong1, Jeffrey L Mills, Bishwajit Kundu, Xinyi Li, Liuting Qing, Krystyna Surewicz, Ignazio Cali, Shenghai Huang, Mengjie Zheng, Wieslaw Swietnicki, Frank D Sönnichsen, Pierluigi Gambetti, Witold K Surewicz.   

Abstract

Prion diseases, or transmissible spongiform encephalopathies (TSEs), are associated with the conformational conversion of the cellular prion protein, PrP(C), into a protease-resistant form, PrP(Sc). Here, we show that mutation-induced thermodynamic stabilization of the folded, α-helical domain of PrP(C) has a dramatic inhibitory effect on the conformational conversion of prion protein in vitro, as well as on the propagation of TSE disease in vivo. Transgenic mice expressing a human prion protein variant with increased thermodynamic stability were found to be much more resistant to infection with the TSE agent than those expressing wild-type human prion protein, in both the primary passage and three subsequent subpassages. These findings not only provide a line of evidence in support of the protein-only model of TSEs but also yield insight into the molecular nature of the PrP(C)→PrP(Sc) conformational transition, and they suggest an approach to the treatment of prion diseases.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23871665      PMCID: PMC3766954          DOI: 10.1016/j.celrep.2013.06.030

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  40 in total

1.  Autocatalytic conversion of recombinant prion proteins displays a species barrier.

Authors:  Ilia V Baskakov
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

2.  Evidence for assembly of prions with left-handed beta-helices into trimers.

Authors:  Cédric Govaerts; Holger Wille; Stanley B Prusiner; Fred E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-21       Impact factor: 11.205

3.  From conversion to aggregation: protofibril formation of the prion protein.

Authors:  Mari L DeMarco; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

Review 4.  The state of the prion.

Authors:  Charles Weissmann
Journal:  Nat Rev Microbiol       Date:  2004-11       Impact factor: 60.633

5.  Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis.

Authors:  T Pan; M Colucci; B S Wong; R Li; T Liu; R B Petersen; S Chen; P Gambetti; M S Sy
Journal:  J Biol Chem       Date:  2001-08-06       Impact factor: 5.157

6.  Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.

Authors:  David L Vanik; Witold K Surewicz
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

Review 7.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 8.  Prion diseases--close to effective therapy?

Authors:  Neil R Cashman; Byron Caughey
Journal:  Nat Rev Drug Discov       Date:  2004-10       Impact factor: 84.694

9.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

Review 10.  Mammalian prion biology: one century of evolving concepts.

Authors:  Adriano Aguzzi; Magdalini Polymenidou
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

View more
  6 in total

1.  Thermodynamic characterization of the unfolding of the prion protein.

Authors:  Roumita Moulick; Jayant B Udgaonkar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

2.  The role of Cys179-Cys214 disulfide bond in the stability and folding of prion protein: insights from molecular dynamics simulations.

Authors:  Lulu Ning; Jingjing Guo; Nengzhi Jin; Huanxiang Liu; Xiaojun Yao
Journal:  J Mol Model       Date:  2014-02-11       Impact factor: 1.810

3.  Heparin binding confers prion stability and impairs its aggregation.

Authors:  Tuane C R G Vieira; Yraima Cordeiro; Byron Caughey; Jerson L Silva
Journal:  FASEB J       Date:  2014-03-19       Impact factor: 5.191

4.  Interplay of buried histidine protonation and protein stability in prion misfolding.

Authors:  Anatoly Malevanets; P Andrew Chong; D Flemming Hansen; Paul Rizk; Yulong Sun; Hong Lin; Ranjith Muhandiram; Avi Chakrabartty; Lewis E Kay; Julie D Forman-Kay; Shoshana J Wodak
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

5.  The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro.

Authors:  Ryo P Honda; Kazuo Kuwata
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

6.  Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease.

Authors:  Zhen Zheng; Meilan Zhang; Yongheng Wang; Rongsheng Ma; Chenyun Guo; Liubin Feng; Jihui Wu; Hongwei Yao; Donghai Lin
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.